Literature DB >> 10903435

Structure of the human MMP-19 gene.

M S Mueller1, S Mauch, R Sedlacek.   

Abstract

The recently identified MMP-19 belongs to the multi-protein family of zinc-binding matrix metalloproteinases (MMP). In order to analyze its genomic organization and to identify transcription factor binding sites that may be involved in the regulation of human MMP-19 expression, the gene coding for MMP-19 has been cloned and sequenced. The MMP-19 gene spans over 7.6kb and is composed of nine exons and eight introns. Furthermore, a 1.9kb fragment of 5'-flanking DNA was isolated and the transcription start point mapped. Nucleotide sequence analysis of its 5'-flanking region revealed several potential transcription factor binding sites typical of MMP promoters. Thus, a TATA-box, a consensus AP-1 binding element, and a putative PEA3 site were identified. The 1.9kb MMP-19 promoter fragment and several deletion constructs thereof were able to drive transcription of the luciferase reporter gene in transiently transfected CHO cells. Finally, it has been shown by an electrophoretic mobility shift assay that the AP-1 consensus sequence is able to bind a HeLa nuclear extract derived AP-1 factor.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10903435     DOI: 10.1016/s0378-1119(00)00236-5

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  8 in total

1.  Overexpression of asparagine synthetase and matrix metalloproteinase 19 confers cisplatin sensitivity in nasopharyngeal carcinoma cells.

Authors:  Ran-Yi Liu; Zizheng Dong; Jianguo Liu; Ling Zhou; Wenlin Huang; Sok Kean Khoo; Zhongfa Zhang; David Petillo; Bin Tean Teh; Chao-Nan Qian; Jian-Ting Zhang
Journal:  Mol Cancer Ther       Date:  2013-08-16       Impact factor: 6.261

Review 2.  Matrix metalloproteinases as therapeutic targets for idiopathic pulmonary fibrosis.

Authors:  Vanessa J Craig; Li Zhang; James S Hagood; Caroline A Owen
Journal:  Am J Respir Cell Mol Biol       Date:  2015-11       Impact factor: 6.914

3.  Promoter characterization of the novel human matrix metalloproteinase-26 gene: regulation by the T-cell factor-4 implies specific expression of the gene in cancer cells of epithelial origin.

Authors:  George N Marchenko; Natalia D Marchenko; Jay Leng; Alex Y Strongin
Journal:  Biochem J       Date:  2002-04-15       Impact factor: 3.857

Review 4.  Matrix metalloproteinases: protective roles in cancer.

Authors:  Julie Decock; Sally Thirkettle; Laura Wagstaff; Dylan R Edwards
Journal:  J Cell Mol Med       Date:  2011-06       Impact factor: 5.310

5.  Diet-induced obesity and reduced skin cancer susceptibility in matrix metalloproteinase 19-deficient mice.

Authors:  Alberto M Pendás; Alicia R Folgueras; Elena Llano; John Caterina; Françoise Frerard; Francisco Rodríguez; Aurora Astudillo; Agnès Noël; Henning Birkedal-Hansen; Carlos López-Otín
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

6.  Matrix metalloproteinase-19 inhibits growth of endothelial cells by generating angiostatin-like fragments from plasminogen.

Authors:  Rena Brauer; Inken M Beck; Martin Roderfeld; Elke Roeb; Radislav Sedlacek
Journal:  BMC Biochem       Date:  2011-07-25       Impact factor: 4.059

7.  Human MMP28 expression is unresponsive to inflammatory stimuli and does not correlate to the grade of intervertebral disc degeneration.

Authors:  Marina Klawitter; Lilian Quero; Alessando Bertolo; Marco Mehr; Jivko Stoyanov; Andreas G Nerlich; Juergen Klasen; Nikolaus Aebli; Norbert Boos; Karin Wuertz
Journal:  J Negat Results Biomed       Date:  2011-07-29

8.  MMP19 is essential for T cell development and T cell-mediated cutaneous immune responses.

Authors:  Inken M Beck; René Rückert; Katja Brandt; Markus S Mueller; Thorsten Sadowski; Rena Brauer; Peter Schirmacher; Rolf Mentlein; Radislav Sedlacek
Journal:  PLoS One       Date:  2008-06-04       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.